Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 2—February 2007
Research

Community-associated Methicillin-resistant Staphylococcus aureus Isolates and Healthcare-Associated Infections1

Cynthia L. Maree*, Robert S. Daum†, Susan Boyle-Vavra†, Kelli Matayoshi‡2, and Loren G. Miller*‡Comments to Author 
Author affiliations: *David Geffen School of Medicine at the University of California, Los Angeles, California, USA; †University of Chicago, Chicago, Illinois, USA; ‡Los Angeles Biomedical Institute at Harbor-UCLA Medical Center, Torrance, California, USA;

Main Article

Figure

Percentage of methicillin-resistant Staphylococcus isolates that are SCCmec type IV phenotype, 1999–2004

Figure. Percentage of methicillin-resistant Staphylococcus isolates that are SCCmec type IV phenotype, 1999–2004

Main Article

1Findings from this investigation were presented in part at the 45th Annual International Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, USA, December 2005.

2Current affiliation: University of Southern California School of Pharmacy, Los Angeles, California

Page created: June 29, 2010
Page updated: June 29, 2010
Page reviewed: June 29, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external